These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 20798652)

  • 21. Economic cost of Guillain-Barré syndrome in the United States.
    Frenzen PD
    Neurology; 2008 Jul; 71(1):21-7. PubMed ID: 18591502
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Total costs of IBS: employer and managed care perspective.
    Cash B; Sullivan S; Barghout V
    Am J Manag Care; 2005 Apr; 11(1 Suppl):S7-16. PubMed ID: 15926759
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The distribution of 10-Year risk for coronary heart disease among US adults: findings from the National Health and Nutrition Examination Survey III.
    Ford ES; Giles WH; Mokdad AH
    J Am Coll Cardiol; 2004 May; 43(10):1791-6. PubMed ID: 15145101
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prediction of prospective medical claims and absenteeism costs for 1284 hourly workers from a manufacturing company.
    Yen LT; Edington DW; Witting P
    J Occup Med; 1992 Apr; 34(4):428-35. PubMed ID: 1564582
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Model-based simulation to explore the cost-effectiveness of following practice guidelines for triglyceride and low-density lipoprotein cholesterol control among patients with diabetes mellitus and mixed dyslipidemia.
    Sorensen SV; Frick KD; Wade A; Simko R; Burge R
    Clin Ther; 2009 Apr; 31(4):862-79. PubMed ID: 19446159
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Demographic risk factors derived from HMO data.
    Hayes ST
    Adv Health Econ Health Serv Res; 1991; 12():177-96. PubMed ID: 10122801
    [No Abstract]   [Full Text] [Related]  

  • 27. [Economic burden of coronary heart disease and stroke attributable to hypertension in China].
    Zhai Y; Hu JP; Kong LZ; Zhao WH; Chen CM
    Zhonghua Liu Xing Bing Xue Za Zhi; 2006 Sep; 27(9):744-7. PubMed ID: 17299955
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cost of gastro-oesophageal reflux disease to the employer: a perspective from the United States.
    Brook RA; Wahlqvist P; Kleinman NL; Wallander MA; Campbell SM; Smeeding JE
    Aliment Pharmacol Ther; 2007 Sep; 26(6):889-98. PubMed ID: 17767473
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The cost-effectiveness of HMG-CoA reductase inhibitors to prevent coronary heart disease. Estimating the benefits of increasing HDL-C.
    Hamilton VH; Racicot FE; Zowall H; Coupal L; Grover SA
    JAMA; 1995 Apr; 273(13):1032-8. PubMed ID: 7897787
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The burden of illness associated with renal cell carcinoma in the United States.
    Lang K; Danchenko N; Gondek K; Schwartz B; Thompson D
    Urol Oncol; 2007; 25(5):368-75. PubMed ID: 17826652
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Forecasting coronary heart disease incidence, mortality, and cost: the Coronary Heart Disease Policy Model.
    Weinstein MC; Coxson PG; Williams LW; Pass TM; Stason WB; Goldman L
    Am J Public Health; 1987 Nov; 77(11):1417-26. PubMed ID: 3661794
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Health care trends in today's marketplace.
    Berger J; Dauten MS
    Empl Benefits J; 1999 Dec; 24(4):11, 13-6. PubMed ID: 10662385
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Coronary disease and social security. A simulation model on cost analysis].
    Hinzpeter B; Klever-Deichert G; Wendland G; Lauterbach KW
    Herz; 2000 Aug; 25(5):515-25. PubMed ID: 10993000
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predicting the impact of population level risk reduction in cardio-vascular disease and stroke on acute hospital admission rates over a 5 year period--a pilot study.
    Whitfield MD; Gillett M; Holmes M; Ogden E
    Public Health; 2006 Dec; 120(12):1140-8. PubMed ID: 17084425
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Direct cost burden among insured US employees with migraine.
    Hawkins K; Wang S; Rupnow M
    Headache; 2008 Apr; 48(4):553-63. PubMed ID: 18070057
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Estimated effects of reducing dietary saturated fat intake on the incidence and costs of coronary heart disease in the United States.
    Oster G; Thompson D
    J Am Diet Assoc; 1996 Feb; 96(2):127-31. PubMed ID: 8557937
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Estimated coronary heart disease attributable to insulin resistance in populations with and without type 2 diabetes mellitus.
    Strutton DR; Stang PE; Erbey JR; Lydick E
    Am J Manag Care; 2001 Aug; 7(8):765-73. PubMed ID: 11519236
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Validation of a population coronary disease predictive system: the CASSANDRA model.
    Grau M; Subirana I; Vila J; Elosua R; Ramos R; Sala J; Dégano IR; Tresserras R; Bielsa O; Marrugat J
    J Epidemiol Community Health; 2014 Nov; 68(11):1012-9. PubMed ID: 24619990
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Measuring the relationship between employees' health risk factors and corporate pharmaceutical expenditures.
    Burton WN; Chen CY; Conti DJ; Schultz AB; Edington DW
    J Occup Environ Med; 2003 Aug; 45(8):793-802. PubMed ID: 12915781
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Employer burden of mild, moderate, and severe major depressive disorder: mental health services utilization and costs, and work performance.
    Birnbaum HG; Kessler RC; Kelley D; Ben-Hamadi R; Joish VN; Greenberg PE
    Depress Anxiety; 2010; 27(1):78-89. PubMed ID: 19569060
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.